Search research articles
Contact Us
Filters
Showing results (361-370 of 378) with videos related to
Page
of 38
Sort By:
Cell Reports. Medicine
|
November 5, 2022
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Mark P G Dings, Amber P van der Zalm, Sanne Bootsma, et al.
Nature Communications
|
August 20, 2016
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus
Pierre Martinez, Margriet R Timmer, Chiu T Lau, et al.
Trials
|
September 5, 2024
Omentum preservation versus complete omentectomy in gastrectomy for gastric cancer (OMEGA trial): study protocol for a randomized controlled trial
K Keywani, W J Eshuis, A B J Borgstein, et al.
International Journal of Cancer
|
July 25, 2019
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
Marin Strijker, Eline C Soer, Matteo de Pastena, et al.
Gastrointestinal Endoscopy
|
August 1, 2020
Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia
Maarten R Struyvenberg, Albert J de Groof, Roger Fonollà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2021
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Tom van den Ende, Nicolien C de Clercq, Mark I van Berge Henegouwen, et al.
Endoscopy
|
September 30, 2021
Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures
Sanne N van Munster, Eva P D Verheij, Esther A Nieuwenhuis, et al.
Annals of Surgery
|
October 9, 2019
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study
Berend J van der Wilk, Bo J Noordman, Lisanne K A Neijenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2019
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
Charlotte I Stroes, Sandor Schokker, Aafke Creemers, et al.
Histopathology
|
February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group
Ylva A Weeda, Roberto Salgado, Filip van Herpe, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 378) with videos related to
Sort By:
Page
of 38
Cell Reports. Medicine
|
November 5, 2022
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Mark P G Dings, Amber P van der Zalm, Sanne Bootsma, et al.
Nature Communications
|
August 20, 2016
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus
Pierre Martinez, Margriet R Timmer, Chiu T Lau, et al.
Trials
|
September 5, 2024
Omentum preservation versus complete omentectomy in gastrectomy for gastric cancer (OMEGA trial): study protocol for a randomized controlled trial
K Keywani, W J Eshuis, A B J Borgstein, et al.
International Journal of Cancer
|
July 25, 2019
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
Marin Strijker, Eline C Soer, Matteo de Pastena, et al.
Gastrointestinal Endoscopy
|
August 1, 2020
Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia
Maarten R Struyvenberg, Albert J de Groof, Roger Fonollà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2021
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Tom van den Ende, Nicolien C de Clercq, Mark I van Berge Henegouwen, et al.
Endoscopy
|
September 30, 2021
Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures
Sanne N van Munster, Eva P D Verheij, Esther A Nieuwenhuis, et al.
Annals of Surgery
|
October 9, 2019
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study
Berend J van der Wilk, Bo J Noordman, Lisanne K A Neijenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2019
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
Charlotte I Stroes, Sandor Schokker, Aafke Creemers, et al.
Histopathology
|
February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group
Ylva A Weeda, Roberto Salgado, Filip van Herpe, et al.
Page
of 38